Latest News | Alembic Pharma Q3 Net Profit Declines 29 Pc to Rs 122 Crore

New Delhi, Feb 2 (PTI) Alembic Pharmaceuticals on Thursday said its consolidated net profit declined by 29 per cent to Rs 122 crore in the December quarter.

The Vadodara-based drug maker had reported a net profit of Rs 172 crore in the October-December quarter of last fiscal.

Also Read | Adani Group Firms Lose USD 100 Billion After Gautam Adani Withdrew FPO, Domestic Markets Remain Steady.

Revenue from operations rose to Rs 1,509 crore in the period under review from Rs 1,272 crore in the year-ago period, Alembic Pharmaceuticals said in a statement.

"The company witnessed top-line growth across all the verticals. In particular, the API business outperformed with a 65 per cent growth during the quarter," Alembic Pharmaceuticals Managing Director Pranav Amin stated.

Also Read | Delhi Weather Update: People To Get Respite From Cold, Rainfall Not Expected for a Week, Says IMD.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)